Research & Development

Can Gene Therapy Transform Hemophilia B Treatment Forever?
Research & Development Can Gene Therapy Transform Hemophilia B Treatment Forever?

Modern medicine continually strives to overcome the limitations of traditional treatments for rare genetic disorders, seeking transformative solutions that can significantly improve patients' lives. Among these conditions, hemophilia B—a genetic disorder inhibiting blood clotting primarily in

Enhancing CAR-T Cells to Combat Solid Tumors with CRISPR
Research & Development Enhancing CAR-T Cells to Combat Solid Tumors with CRISPR

In recent years, the battle against cancer has seen the emergence of innovative approaches, particularly in immunotherapy. Chimeric Antigen Receptor (CAR) T cell therapy, famously effective against blood cancers, faces significant hurdles when applied to solid tumors. A critical challenge is the

Boosting Pediatric Trials: KU and UNMC's $31M NIH Grant
Research & Development Boosting Pediatric Trials: KU and UNMC's $31M NIH Grant

The University of Kansas Medical Center (KU Medical Center) and the University of Nebraska Medical Center (UNMC) have embarked on an ambitious endeavor to revolutionize pediatric clinical research, with a significant boost from a $31 million grant awarded by the National Institutes of Health (NIH).

Mitochondrial Drugs Revolutionize Melanoma Treatment Strategies
Research & Development Mitochondrial Drugs Revolutionize Melanoma Treatment Strategies

In recent months, pivotal discoveries in melanoma research have unveiled game-changing insights that could reshape the therapeutic landscape for one of the most aggressive skin cancers. Traditionally, treatment options for melanoma have struggled with effectively targeting the disease due to its

Revolutionizing Health: GLP-1 Drugs' Impact on Society and Medicine
Research & Development Revolutionizing Health: GLP-1 Drugs' Impact on Society and Medicine

In the realm of modern medicine, few breakthroughs have garnered as much attention and promise as GLP-1 receptor agonists. Initially developed to combat type 2 diabetes, these medications have broadened their scope to address obesity, cardiovascular issues, and more. Ivan Kairatov, a renowned

Telehealth Revolution in Geriatric Cancer Care with GAIN-S
Research & Development Telehealth Revolution in Geriatric Cancer Care with GAIN-S

How is telehealth reshaping the future of cancer care for older adults? In rural areas where healthcare facilities are sparse, imagine an 80-year-old gentleman with sparkling eyes sitting comfortably in his favorite chair, meeting his oncologist virtually. He accesses his treatment plan from a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later